
Isomorphic Labs raised $600M in its first external funding round
AI drug design company Isomorphic Labs has secured $600 million in funding led by Thrive Capital to accelerate development of its AI platform, expand partnerships with pharmaceutical giants, and advance therapeutic programs into clinical trials.